ABSTRACT
Results: A total of 465 patients with a mean (AESD) age of 82 (AE7) years were included, 283 (61.0%) being female and 225 (51.3%) with severe comorbidity (Charlson index ≥ 3). Frailty was present in 169 (36.3%). The rate of 30-day mortality was 7.3%. Frailty adjusted for potential confounding factors was an independent factor associated with 30-day mortality (adjusted hazard ratio = 2.5; 95% confidence interval = 1.0 to 6.0; p = 0.047).
Conclusion:
The presence of frailty is an independent risk factor of 30-day mortality in nonsevere dependent older patients attended with AHF in EDs.
H eart failure (HF) is a chronic disease with an agedependent incidence. Three of four patients with acute HF (AHF) are older than 75 years. 1 Decompensation episodes are common causes of visits to the emergency department (ED) and the main reason for hospitalization of these patients in developed countries. [2] [3] [4] Older patients with acute HF (AHF) require a more complex evaluation and have a worse short-term prognosis compared to younger adults. 5, 6 These worse outcomes are probably more related to comorbidity, frailty, and disability than to age. 5, [7] [8] [9] [10] Frailty is defined as a dynamic and nonlinear process that describes a state of vulnerability (reduced system reserves and capacity of response to stress situations) to stressors in older populations. 11 There are two main models frequently used to categorize frailty, the biologic syndrome model (frailty phenotype) and an accumulation of deficits model (frailty index). 11 This biologic syndrome requires the presence of three or more of five domains: 1) exhaustion, 2) unintentional weight loss, 3) impaired grip strength, 4) slowness, and 5) low physical activity. 12 Numerous studies have modified the original criteria of frailty phenotype proposed by Fried et al. 12, 13 Frailty is very frequent in older patients admitted for AHF. 14, 15 Moreover, the frailty syndrome contributes to adverse short-and long-term outcomes in patients with AHF. [16] [17] [18] Most studies carried out for evaluation of the frailty on HF are based on tools derived from the frailty phenotype. A recent study has reported that the presence of the frailty phenotype in older patients with nonestablished severe disability is associated with long-term adverse outcomes. 18 This finding has been described in admitted older patients with AHF and through tests carried out during or at the end of hospitalization, but not in older patients evaluated in the first hours of presenting in the ED. [16] [17] [18] The current European AHF guideline recommends assessing the level of frailty, particularly in older patients without nonestablished disability, with the aim of developing a care plan.
19-21
Approximately one-quarter of patients attended in the ED are discharged home 1 and, therefore, emergency physicians have a crucial role in discharge care planning. Recommendations based on decision rules have recently been published to help emergency physicians in decision-making as to admit or discharge patients with acute HF from the ED. 22, 23 These decision rules include demographic data, comorbidities, biomarkers, and even measures of severe dependence, 8, [24] [25] [26] but do not consider frailty in nondependent older patients. 27 Despite these findings, no studies have yet been performed in the ED to evaluate the impact of frailty, as a predisability status on the short-term outcomes of older patients presenting with AHF. If the frailty phenotype is associated with the 30-day mortality in nonseverely disabled older patients with AHF in the ED, it should be routinely assessed and taken into account in ED risk stratification of AHF in these patients. The aim of this study was to determine if the presence of frailty is an independent factor associated with 30-day mortality in nonseverely disabled older patients with AHF attended in the ED.
METHODS

Study Design
The Frailty-AHF Study is a retrospective preplanned secondary analysis of the Older-AHF Register, a prospective observational multicenter cohort study, using a sample of convenience limited by the day and the time. The present study was approved by the clinical ethical Committees of all the participating hospitals.
Patients and Setting
The Older-AHF Register prospectively included all patients ≥ 65 years attended with AHF in three Spanish EDs (HCSC, Madrid; HRS, Murcia; and HSCSP, Barcelona), for 4 months, in 2-month periods (November-December 2011 and January-February 2014). Patients were initially selected by attending emergency physicians considering clinical, electrocardiographic, and radiologic findings and, if available, natriuretic peptide levels and bedside ultrasound features. The principal investigator of each center reviewed all the cases and finally included those cases fulfilling the diagnostic criteria of the HF guidelines of the European Society of Cardiology (ESC). 28 The exclusion criteria were a diagnosis of ST-segment elevation acute myocardial infarction concomitant with AHF or nonconsent to participate in the study.
For the Frailty-AHF Study, we selected older patients included in the Older-AHF Register with frailty (Fried criteria) assessment who did not have severe functional dependence (Barthel index ≥ 40 points) or previous diagnosis of dementia. Patients without data related to the degree of disability (Barthel index) and vital status in the first 30-day after the index visit were excluded from the analyses (Figure 1 ).
Variables
The attending emergency physicians collected the following data: demographic data (age and sex), medical history (arterial hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, chronic renal failure, cerebrovascular disease, atrial fibrillation, peripheral artery disease, valve disease, chronic obstructive pulmonary disease, hepatic cirrhosis, cancer, previous diagnosis of HF, and left ventricular ejection fraction), grade of comorbidity (Charlson index), baseline cardiorespiratory performance (New York Heart Association [NYHA] class), acute episode data (cardiac and respiratory rates, systolic blood pressure, oxygen saturation measured by pulse oximetry, NYHA class for the episode, hemoglobin, sodium, blood urea nitrogen, renal clearance by MDRD-4, and NT-proBNP), and treatment requirements (oxygen, noninvasive ventilation, intravenous diuretics, nitroglycerin, angiotensinconverting enzyme inhibitors, angiotensin receptor blocker, beta-blockers, and digoxin), severity of episode (CHF Risk Model [Heart Failure Risk Scoring System {HFRSS}] from the EFFECT [Enhanced Feedback for Effective Cardiac Treatment]), 24 and final destination. A brief geriatric assessment that included frailty and baseline activities of daily living (Barthel index) was performed by a trained physician of each center, who was not responsible for the care of the patient, during the first 12 hours of care in the ED during weekdays (Monday to Friday), from 8 AM to 10 PM.
According to the Fried criteria, 12 frailty was defined as the presence of three or more positive responses to the following self-reported questions: 1) Exhaustion: Do you usually feel that everything you do is an effort and you cannot get going? 2) Grip strength: Do you have difficulty standing up from a chair? 3) Walking time: Do you have significant difficulty in walking outside of the dwelling? 4) Physical activity: Do you rarely ever engage in physical activity? 5) Weight loss: Have you unintentionally lost weight in the last year? 13, 21 The main outcome was all-cause mortality within 30 days after attending the ED and was obtained through a review of the clinical history of each patient or by a telephone call to the patient or a relative 31 to 60 days after discharge.
Data Analysis
Quantitative variables were expressed as means and standard deviation (SD) or median and interquartile Figure 1 . Flowchart of patients included in the Frailty-AHF Study. AHF = acute heart failure.
ranges, and qualitative variables as absolute numbers and percentages. For univariate comparisons the Student's t-test was used for the quantitative variables if they adjusted to a normal distribution (determined using the Kolmogorov-Smirnov test) or with the nonparametric test of the median in cases without a normal distribution. The chi-square or the Fisher exact test was used for qualitative variables. p-values are reported for these comparisons as those with p < 0.1 were included in multivariable models. Survival curves were constructed using the Kaplan-Meier model. Global differences between the different survival curves were determined using log-rank statistics, and each group was compared with nonfrail group, which was used as the reference group. The effect of the frailty phenotype and frailty domains on 30-day mortality was expressed as crude hazard ratios (HRs), with 95% confidence intervals (CIs), and then adjusted HR by all potential confounding factors (p < 0.10), using a direct Cox regression analysis. The CHF Risk Model (HFRSS) from the EFFECT study was used to calculate the risk score for 30-day mortality (http://www.ccort. ca/Research/CHFRiskModel.aspx). In relation to 30-day mortality, this scale includes age, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, hepatic cirrhosis and cancer, as well as the respiratory rate, systolic blood pressure, blood urea nitrogen, and sodium concentrations at ED admission. Missing data of the respiratory rate and the NT-proBNP value obtained at ED arrival were imputed by mean or nearby median points, respectively. The proportionality of hazards and the colinearity were analyzed using the proportional hazards assumption test based on Schoenfand residuals and the covariance of the estimated parameters by the model. Harrell's C of the CHF risk model with and without frailty were compared using a nonparametric test for investigating the discrimination of models with and without frailty. We considered differences to be statistically significant if the p-value was less than 0.05 and the 95% CI of the HR excluded 1. All the analyses were performed with SPSS 18.0 statistical package with the exception of the comparison of Harrell's C which was carried out with the STATA 12.0 statistical package.
RESULTS
Of the 1,007 patients with AHF, 952 were consecutively included in the Older-AHF Register (see Appendix A) of which 220 did not meet the selection criteria, 242 did not undergo the brief geriatric,assessment and 25 did not have 30-day follow-up. Therefore, 465 of 732 (64%) eligible patients were ultimately included in Frailty-AHF Study (Figure 1) . Compared with the remaining eligible patients, those included in this study showed significant differences in ischemic heart disease, cardiorespiratory, and functional basal status and NT-proBNP levels (see Data Supplement S1, Table S1 , available as supporting information in the online version of this paper Of the total number of patients, 169 (36.3%) fulfilled the frailty criteria that include deficit in three or more domains. According to individual domains, exhaustion was present in 46.8%, physical activity in 44.1%, grip strength in 42.7%, walking time in 36.3%, and weight loss in 27.0%. Compared to nonfrail patients, those who were frail were older, were more often female, and had significantly more frequent arterial hypertension, previous diagnosis of HF, and a higher basal level of dependence, NYHA class, severity of episode (CHF risk model), and NT-proBNP levels. There were no differences between the two groups regarding treatment received in the ED or final destination (Tables 1 and 2 ).
The overall rate of 30-day mortality was 7.3%, being markedly different between frail and nonfrail patients, 13.0% versus 4.1%, respectively (p < 0.001). After adjusting for all potential confounding factors (see Data Supplement S1, Tables S2 and S3), the presence of frailty was independently associated with 30-day mortality (adjusted HR = 2.5; 95% CI = 1.0-6.0; p = 0.047). Figure 2 shows the HRs of frailty and of each of its different domains. Figure 3 reflects the survival curves by the number of frailty domains.
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The Harrell's C of the CHF risk model was 0.68, being 0.74 with the addition of frailty, without significant differences between the two models were no significant (p = 0.279). Figure 4 shows the predicted probability of 30-day mortality in the different risk categories of the CHF Risk Model stratified by the presence of frailty.
DISCUSSION
The results of the Frailty-AHF Study show that the presence of the frailty phenotype, assessed with the use of a self-reported questionnaire, is an independent factor associated with 30-day mortality in nonseverely disabled older patients with AHF attended in the ED. This finding may be of clinical relevance because of the impact of frailty on short-term mortality. In addition, frailty is a dynamic state, which is potentially reversible with adequate treatment 29, 30 including comorbidity optimization, exercise, and protein-calorie supplementation. 21, 31, 32 Therefore, the identification of frailty may help emergency physicians to design the care plan of older patients with AHF and more specifically the most adequate early treatment and the final destination.
It is well known that frailty is frequently present in older patients with chronic diseases. 11 It is generally associated with a poor survival, and this relationship is stronger in those with more deficits. 33 Our study adds to the knowledge of the association of frailty and increased short-term mortality also in AHF. This information is relevant because the development of AHF is a common reason for ED visits among older people, and frailty can be easily identified and may be reversible, at least in part.
With regard to AHF, previous studies have suggested that frailty in older nondependent patients admitted to the hospital is a predictor of adverse shortand long-term outcomes. 14, 18, 34 This study provides additional evidence of the effect of the frailty phenotype on 30-day mortality in nonseverely disabled older patients with AHF attended in the ED. In contrast to these previous studies in which the evaluation was carried out during or at the end of the hospitalization, 14, 18, 34 in this study frailty was assessed during the first hours of acute care. This situation was the main reason for assessing the frailty phenotype with the use of five self-reported questions, and not the original Fried criteria, to save time and make the assessment of frailty feasible in the ED setting. Data are reported as mean (AESD) or n (%). AHF = acute heart failure; NYHA = New York Heart Association.
Although the value of self-reported estimates of frailty remains under debate, we concur with other authors in relation to the validity of this approach, especially when performance criteria are difficult to evaluate. 13 In this regard, we considered two selfreported questions adopted from the literature to evaluate 1) the grip strength criterion (difficulty in standing up from a chair) and 2) the walking time criterion (having significant difficulty in walking outside of the dwelling). 13, 35 In this study the latter criterion was slightly modified to a more specific question (any difficulty for walking 100 m) as recommended in a recent review. 21 Therefore, these modifications of the original criteria might have an impact on its estimated effect, and this should be taken into account when interpreting our findings. 13 In our study, frailty occurred in approximately one of three older nonseverely dependent patients with AHF attended in the ED. This was lower than the 50%-75% described by previous studies conducted in patients hospitalized for AHF. 14, 15, 18, 36 This may be due to our study having been carried out in the ED and included both patients admitted to hospital and patients discharged directly from the ED. The latter patients are typically those in the lower risk categories for adverse events and probably include a larger number of patients without frailty or functional limitations. 1 Models classically used to predict 30-day mortality are based on age, comorbidity, and data regarding the presenting acute episode. 8, [24] [25] [26] It is well recognized that older patients with severe functional dependence have an increased 30-day mortality risk compared to those without severe disability. 7, 8 Our data show that frailty has a significant effect on 30-day mortality in nonseverely disabled older patients with AHF, who are a priori considered as a group of lower risk in comparison with patients with dependence. This result Data are reported as n (%) or median (IQR). ACE-I = angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blocker; BB = beta-blocker; Erc = estimated renal clearance; Hb = hemoglobin; IQR = interquartile range; NYHA = New York Heart Association; rpm = respiration per minute; SBP = systolic blood pressure. *NT-proBNP value at ED arrival available in 332 patients (111 frailty and 221 nonfrailty).
ACADEMIC EMERGENCY MEDICINE • March 2017, Vol. 24, No. 3 • www.aemj.org adds to the growing body of evidence demonstrating the need to assess the frailty phenotype to stratify the prognosis of older patients without nonsevere dependence. 21, 37 In this study, the addition of frailty to the CHF risk model did not demonstrate a higher discriminative capacity, probably because of a type II error. The trend of improvement observed (Harrell's C increased from 0.68 to 0.74) underlines the need to confirm this hypothesis with a more highly powered study. 38 
LIMITATIONS
This study has a number of limitations, which should be acknowledged. First, the sample size was not calculated a priori because this was an exploratory analysis in a large multipurpose cohort. This may have limited the statistical power of the analysis. Second, the results are only applicable to the study population, that is, nonseverely dependent AHF patients, aged 65 years or older, without a previous diagnosis of dementia. However, most experts recommend that patients with cognitive impairment or severe disability are excluded from studies that examine frailty using the frailty phenotype tool. 12 Third, some selection bias cannot be ruled out because the results were derived from a voluntary multicenter registry and frailty assessment was performed between 8 AM and 10 PM on weekdays. Nonetheless, differences between the patients included and not included were analyzed and considered for adjustment in our models. Fourth, although potential confounders, such as echocardiographic or some plasma biomarker results, which are not routinely performed in patients with AHF attended in Spanish EDs, might have some influence on the results, our approach is more realistic and is ultimately easier to apply in real ED practice. In addition, as in any multivariable post hoc analysis, not all the cofounders were *Adjusted by sex, arterial hypertension, atrial fibrillation, previous diagnostic of heart failure, Barthel index, baseline NYHA class, tachycardia, hypoxemia, anemia, CHF risk model, and NT-proBNP. CHF = congestive heart failure; HR = hazard ratio; NYHA = New York Heart Association.
taken into account, and some nonrecorded variables may have inadvertently influenced the results. Finally, treatments prescribed at discharge were not controlled but left to the attending physician's criteria with no specific guidance, and this may have had some influence on outpatient outcome. Our study also has a number of strengths. Namely, it is the first study performed in ED patients, with prospective data collection and multicenter participation.
CONCLUSION
We conclude that the presence of frailty measured by self-reported questions is an independent risk factor 
